title: Proteomics and biomarkers for ovarian cancer diagnosis.
abstract: Ovarian cancer remains a leading cause of death from gynecological malignancy. Early diagnosis is the most important determinant of survival. Current diagnostic tools have had very limited success in early detection. In recent years, the advancing techniques for proteomics have accelerated the discovery of ovarian cancer biomarkers. Numerous proteomics-based molecular biomarkers/panels have been identified and hold great potential for diagnostic applications, but they need further development and validation. This article reviews recently published data on the diagnosis of ovarian cancer with proteomics, including the major proteomics technologies and promising strategies for biomarker discovery and development.
authors.affiliation: Department of Biomedicine, Women's Hospital, University of Basel, Basel, Switzerland.
authors.forename: Bei
authors.initials: B
authors.lastname: Zhang
authors.forename: Zeinab
authors.initials: Z
authors.lastname: Barekati
authors.forename: Corina
authors.initials: C
authors.lastname: Kohler
authors.forename: Ramin
authors.initials: R
authors.lastname: Radpour
authors.forename: Reza
authors.initials: R
authors.lastname: Asadollahi
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Holzgreve
authors.forename: Xiao Yan
authors.initials: XY
authors.lastname: Zhong
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism*; D042241:Early Diagnosis; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000378:metabolism*; D040901:Proteomics
chemical_list: D014408:Biomarkers, Tumor